-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
Our Environmental, Social and
Governance Approach
Governance Approach
At its core, Novavax is committed to improving global public health. We focus our sustainability impact on four strategic pillars which guide our efforts to make a positive impact in global health and operate in an environmentally sustainable and inclusive manner.
Maximizing vaccine access and improving global health. We innovate through R&D, business and community partnerships to increase global access to vaccines that target serious infectious diseases
Meeting the highest standards of governance. Novavax is committed to operating with integrity, transparency and accountability in all that we do
Mitigating our environmental impact. We aim to operate in an environmentally sustainable manner that reduces our environmental impact and increases our resilience
Championing diversity, equity and inclusion in our workforce. We seek to build an empowering and diverse work culture, investing in our people to attract and retain the best talent and help our employees, referred to as SuperNovas, achieve their full potential